BioLife Solutions, Inc. (DELISTED) (BLFS:DL)
38.61
0.00 (0.00%)
USD |
NASDAQ |
Oct 15, 16:00
BioLife Solutions Cash from Investing (Quarterly) : -1.579M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.579M |
| March 31, 2026 | -1.83M |
| December 31, 2025 | 1.137M |
| September 30, 2025 | -5.967M |
| June 30, 2025 | -39.53M |
| March 31, 2025 | -27.18M |
| December 31, 2024 | 73.64M |
| September 30, 2024 | -1.681M |
| June 30, 2024 | -13.44M |
| March 31, 2024 | -0.221M |
| December 31, 2023 | 3.957M |
| September 30, 2023 | 1.662M |
| June 30, 2023 | 9.292M |
| March 31, 2023 | 2.926M |
| December 31, 2022 | -14.89M |
| September 30, 2022 | -15.88M |
| June 30, 2022 | -25.07M |
| March 31, 2022 | -2.27M |
| December 31, 2021 | -2.542M |
| September 30, 2021 | -2.007M |
| June 30, 2021 | -4.216M |
| March 31, 2021 | -4.427M |
| December 31, 2020 | -22.06M |
| September 30, 2020 | -0.975M |
| June 30, 2020 | -0.456M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.227M |
| December 31, 2019 | -14.02M |
| September 30, 2019 | -0.292M |
| June 30, 2019 | 143.30M |
| March 31, 2019 | -156.00M |
| December 31, 2018 | -0.1609M |
| September 30, 2018 | -5.278M |
| June 30, 2018 | -1.021M |
| March 31, 2018 | -0.0408M |
| December 31, 2017 | -0.0523M |
| September 30, 2017 | -0.0133M |
| June 30, 2017 | -0.041M |
| March 31, 2017 | -0.0372M |
| December 31, 2016 | -0.2696M |
| September 30, 2016 | -0.1932M |
| June 30, 2016 | -0.2149M |
| March 31, 2016 | 1.070M |
| December 31, 2015 | 0.8232M |
| September 30, 2015 | -0.3963M |
| June 30, 2015 | 2.097M |
| March 31, 2015 | 1.716M |
| December 31, 2014 | -0.0425M |
| September 30, 2014 | -1.929M |
| June 30, 2014 | -6.144M |
| March 31, 2014 | -0.0188M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Repligen Corp. | -2.089M |
| Agilent Technologies, Inc. | -1.032B |
| Danaher Corp. | -10.15B |
| Thermo Fisher Scientific, Inc. | 164.00M |
| West Pharmaceutical Services, Inc. | -43.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.348M |
| Cash from Financing (Quarterly) | -3.594M |
| Free Cash Flow | 7.987M |
| Free Cash Flow Per Share (Quarterly) | 0.1052 |
| Free Cash Flow to Equity (Quarterly) | 4.304M |
| Free Cash Flow to Firm (Quarterly) | 5.185M |
| Free Cash Flow Yield | 0.42% |